IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Qiming U.S. Ventures Management, LLC

Q2 2025 Holdings

Filed 2025-08-14 | 6 holdings | $23.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tourmaline BIO Inc(TRML)COM89157D105$11.9M741,69150.2%
Jasper Therapeutics Inc(JSPR)COM NEW471871202$5.2M928,96421.8%
Korro BIO Inc(KRRO)COM500946108$4.6M368,08519.5%
Ventyx Biosciences Inc(VTYX)COM92332V107$882.2K412,2253.7%
Hillevax IncCOM43157M102$741.5K372,6153.1%
Kezar Life Sciences Inc(KZR)COM NEW49372L209$379.5K82,8711.6%